Data / Drug companies / Metronidazole
Metronidazole: 68 companies and 172 products in the FDA NDC directory
Metronidazole is listed in the FDA National Drug Code Directory by 68 companies, with 172 products in commercial distribution. 159 of the products (92.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, film coated; gel, and the newest product started marketing on October 5, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 68
- Products
- 172
- Generic (ANDA) products
- 159 (92.4%)
- Application numbers
- 44
- Routes
- Oral, Topical, Vaginal, Intravenous
- Brand names
- Flagyl, Vandazole, Noritate, Nuvessa, Vagizole
- openFDA record search
- api.fda.gov
Companies that list metronidazole
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Remedyrepack Inc. | 15 | tablet; tablet, film coated | Generic drugs (ANDA) | October 5, 2026 |
| Bryant Ranch Prepack | 10 | tablet; tablet, film coated | Generic drugs (ANDA) | January 4, 2025 |
| A-S Medication Solutions | 9 | gel; tablet, film coated | Generic drugs (ANDA) | June 24, 2022 |
| NuCare Pharmaceuticals,Inc. | 9 | tablet; tablet, film coated | Generic drugs (ANDA) | February 23, 2019 |
| Alembic Pharmaceuticals Limited | 5 | tablet; gel | Generic drugs (ANDA) | March 17, 2025 |
| Bryant Ranch Prepack | 5 | tablet, film coated; cream | Generic drugs (ANDA) | June 19, 2026 |
| Alembic Pharmaceuticals Inc. | 4 | tablet; capsule | Generic drugs (ANDA) | September 6, 2021 |
| Cosette Pharmaceuticals, Inc. | 4 | gel; cream | Generic drugs (ANDA) | July 12, 2023 |
| Method Pharmaceuticals, LLC | 4 | tablet | Generic drugs (ANDA) | July 1, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | February 23, 2019 |
| Preferred Pharmaceuticals Inc. | 4 | tablet, film coated; cream | Generic drugs (ANDA) | May 23, 2024 |
| Viona Pharmaceuticals Inc | 4 | tablet; gel | Generic drugs (ANDA) | February 14, 2026 |
| Zydus Lifesciences Limited | 4 | tablet; gel | Generic drugs (ANDA) | February 14, 2026 |
| Aurobindo Pharma Limited | 3 | gel; cream | Generic drugs (ANDA) | September 25, 2026 |
| Bryant Ranch Prepack | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | June 1, 2014 |
| Chartwell RX, LLC | 3 | tablet; capsule | Generic drugs (ANDA) | November 29, 2017 |
| Mayne Pharma | 3 | cream; lotion | Authorized generics (NDA) | May 19, 2025 |
| Proficient Rx LP | 3 | tablet; tablet, film coated | Generic drugs (ANDA) | June 1, 2014 |
| Redpharm Drug | 3 | tablet; gel | Generic drugs (ANDA) | August 1, 2018 |
| Sun Pharmaceutical Industries, Inc. | 3 | gel | Generic drugs (ANDA) | April 9, 2019 |
| Alembic Labs LLC | 2 | tablet | Generic drugs (ANDA) | June 26, 2019 |
| American Health Packaging | 2 | tablet | Generic drugs (ANDA) | April 9, 2020 |
| Amici Pharma, Inc. | 2 | tablet | Generic drugs (ANDA) | November 22, 2019 |
| Asclemed USA, Inc. | 2 | tablet | Generic drugs (ANDA) | February 23, 2019 |
| Aurobindo Pharma Limited | 2 | tablet | Generic drugs (ANDA) | May 29, 2015 |
| AvPAK | 2 | tablet | Generic drugs (ANDA) | October 30, 2019 |
| Baxter Healthcare Corporation | 2 | injection, solution | New drug applications (NDA) | December 24, 1981 |
| BluePoint Laboratories | 2 | tablet, film coated | Generic drugs (ANDA) | August 1, 2018 |
| Cadila Pharmaceuticals Limited | 2 | tablet, film coated | Generic drugs (ANDA) | December 29, 2017 |
| Cardinal Health 107, LLC | 2 | tablet | Generic drugs (ANDA) | March 5, 2025 |
| Coupler LLC | 2 | tablet, film coated | Generic drugs (ANDA) | June 16, 2026 |
| E. Fougera & Co. a Division of Fougera Pharmaceuticals, LLC | 2 | lotion; cream | Generic drugs (ANDA) | May 24, 2006 |
| Golden State Medical Supply, Inc. | 2 | tablet | Generic drugs (ANDA) | July 16, 1986 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | November 29, 2017 |
| Kanchan Healthcare Inc | 2 | tablet, film coated | Generic drugs (ANDA) | June 19, 2026 |
| Major Pharmaceuticals | 2 | tablet | Generic drugs (ANDA) | November 29, 2017 |
| Northwind Health Company, LLC | 2 | tablet | Generic drugs (ANDA) | February 28, 2023 |
| PharmPak, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | July 12, 2019 |
| Rising Pharma Holdings, Inc. | 2 | tablet | Generic drugs (ANDA) | May 29, 2015 |
| St. Mary's Medical Park Pharmacy | 2 | tablet; tablet, film coated | Generic drugs (ANDA) | June 17, 2022 |
| Teva Pharmaceuticals USA, Inc. | 2 | tablet | Generic drugs (ANDA) | September 30, 1990 |
| Unichem Pharmaceuticals (USA), Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | June 1, 2014 |
| Amneal Pharmaceuticals Private Limited | 1 | injection, solution | Generic drugs (ANDA) | June 17, 2023 |
| Bausch Health US LLC | 1 | cream | New drug applications (NDA) | August 9, 2013 |
| Civica, Inc. | 1 | injection, solution | New drug applications (NDA) | December 24, 1981 |
| Direct RX | 1 | tablet, film coated | Generic drugs (ANDA) | August 21, 2019 |
| Encube Ethicals, Inc. | 1 | gel | Generic drugs (ANDA) | June 17, 2023 |
| Exeltis USA, Inc. | 1 | gel | New drug applications (NDA) | March 10, 2018 |
| Gland Pharma Limited | 1 | injection, solution | Generic drugs (ANDA) | August 3, 2020 |
| Glenmark Pharmaceuticals Inc., USA | 1 | gel | Generic drugs (ANDA) | January 27, 2022 |
| Henry Schein, Inc. | 1 | injection, solution | Generic drugs (ANDA) | February 24, 2023 |
| Hospira, Inc. | 1 | injection, solution | Generic drugs (ANDA) | December 13, 2021 |
| NorthStar Rx LLC | 1 | gel | Generic drugs (ANDA) | June 24, 2022 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | September 28, 2023 |
| Oceanside Pharmaceuticals | 1 | cream | New drug applications (NDA) | August 1, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | June 1, 2014 |
| Padagis Israel Pharmaceuticals Ltd | 1 | gel | Generic drugs (ANDA) | July 8, 2019 |
| Pfizer Laboratories Div Pfizer Inc | 1 | capsule | New drug applications (NDA) | May 3, 1995 |
| Prasco Laboratories | 1 | cream | Authorized generics (NDA) | June 18, 2009 |
| Quality Care Products, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | June 1, 2014 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | November 15, 2009 |
| Saptalis Pharmaceuticals, LLC. | 1 | gel | Generic drugs (ANDA) | March 3, 2025 |
| Solaris Pharma Corporation | 1 | gel | Generic drugs (ANDA) | January 8, 2026 |
| Sportpharm LLC | 1 | tablet | Generic drugs (ANDA) | February 23, 2019 |
| Sun Pharmaceutical Industries, Inc. | 1 | injection, solution | Generic drugs (ANDA) | August 10, 2021 |
| Upsher-Smith Laboratories, LLC | 1 | gel | New drug applications (NDA) | October 4, 2005 |
| WG Critical Care, LLC | 1 | injection, solution | Generic drugs (ANDA) | January 31, 2025 |
| iNutrition LLC | 1 | gel | Generic drugs (ANDA) | June 29, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 74 | 43% |
| Tablet, film coated | 40 | 23.3% |
| Gel | 30 | 17.4% |
| Cream | 11 | 6.4% |
| Injection, solution | 10 | 5.8% |
| Capsule | 4 | 2.3% |
| Lotion | 2 | 1.2% |
| Tablet, film coated, extended release | 1 | 0.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 159 | 92.4% |
| New drug applications (NDA) | 8 | 4.7% |
| Authorized generics (NDA) | 5 | 2.9% |
Pharmacologic classes
| Class | Products |
|---|---|
| Nitroimidazole Antimicrobial | 172 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.